{"id":"W2804105316","doi":"10.1016/s1470-2045(18)30292-4","title":"Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1011,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa","funders":"Astex Pharmaceuticals; Novartis","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Hormone receptor; Endocrine system; Hormone therapy; Gynecology; Cancer; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00128093,0.001520973,0.002249221,0.0003647828,0.0003501467,0.001013981,0.0009013261,0.00171137,0.01081094],"category_scores_gemma":[0.001387945,0.0005725081,0.002418379,0.0003809478,0.0009553131,0.0008610016,0.0005038374,0.003252038,0.001952367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008575195,"about_ca_system_score_gemma":0.001091216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001872325,"about_ca_topic_score_gemma":0.006678168,"domain_scores_codex":[0.9996374,0.0001801997,0.00001473805,0.0000571874,0.00002735649,0.00008304657],"domain_scores_gemma":[0.9995239,0.0001369125,0.00007237974,0.00004567555,0.00002789953,0.0001933247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9638402,0.003143784,0.0006164248,0.001054655,0.001732935,0.00006409686,0.00006090074,0.0004692136,0.002447357,0.0002248183,0.003085553,0.02325999],"study_design_scores_gemma":[0.9682809,0.02804646,0.001207702,0.00004412474,0.0005235228,0.00004311722,0.00002651235,0.0001890975,0.0001237519,0.0001958062,0.001306857,0.00001219068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9504369,0.02539359,0.0008993712,0.003009056,0.001753179,0.005027988,0.004235759,0.0003420038,0.008901997],"genre_scores_gemma":[0.9533215,0.01319192,0.001962294,0.004401722,0.0009019407,0.006029165,0.005059229,0.00007789171,0.01505444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01081094,"threshold_uncertainty_score":0.03616619,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03244725651231038,"score_gpt":0.3715379082167767,"score_spread":0.3390906517044663,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}